Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shareholder Notice: Lawsuit Alleges Violations of Securities Laws
An investor, who purchased NASDAQ:BCLI shares, filed a lawsuit against Brainstorm Cell Therapeutics Inc over alleged violations of Federal Securities Laws.
View full press release